Approaches to rhythm control: Impact of electrical cardioversion versus pharmacological management on left atrial size and systolic performance in atrial fibrillation and flutter
Medicinski Glasnik · 2025
DOI: 10.17392/1830-22-01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinski Glasnik, 2025. Verfasst von Emir Bećirović und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Clinic, University Clinical Centre Tuzla, Bosnia and Herzegovina.
Abstract (Originalsprache)
<p><strong>Aim</strong> To compare the impact of electrical cardioversion (ECV) and pharmacological cardioversion (PCV) on left atrial size (LA) and left ventricular ejection fraction (LVEF), as well as to identify predictors of rhythm disorder recurrence in patients with atrial fibrillation (AF) or atrial flutter (AFL).<br /><strong>Methods</strong> A prospective observational cohort study was conducted on 105 patients with persistent AF or AFL at the University Clinical Centre Tuzla. The patients were divided into two groups: 53 underwent ECV and 52 received PCV. Demographic and clinical data, including ECG and transthoracic echocardiography, were collected. Follow-up assessments were conducted at 7 days, 1 month, and subsequently every 3 months for a year.<br /><strong>Results</strong> Baseline characteristics were similar between the groups. Recurrence of rhythm disorder within one year was observed in 52.4% of cases, with ECV showing a slightly lower, though not significantly different, primary failure rate at 7 days compared to PCV (13.2% vs. 23.1%). Significant predictors of recurrence included longer duration of disorder (p<0.001), hypertension (p=0.016), lack of pre-cardioversion amiodarone (p=0.027), and larger LA (p<0.001). Both ECV and PCV significantly reduced LA over time, with no significant differences in LVEF between groups.<br /><strong>Conclusion</strong> Both ECV and PCV are effective in restoring sinus rhythm, with a trend towards lower recurrence in the ECV group. Predictors such as disorder duration, hypertension, lack of pre-cardioversion amiodarone, and LA should be considered when planning cardioversion to optimize patient outcomes.</p>
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Clinic, University Clinical Centre Tuzla, Bosnia and Herzegovina.
- Department of Clinical Pharmacology, University Clinical Centre Tuzla, Bosnia and Herzegovina.
- Department of Internal Medicine, Cantonal Hospital Zenica, Bosnia and Herzegovina.
- Department of Pediatrics, General Hospital "Prim. Dr. Abdulah Nakaš" Sarajevo, Bosnia and Herzegovina.
- Department of Neurosurgery, Cantonal Hospital Zenica, Bosnia and Herzegovina.
ORCID-Profile: Emir Bećirović
Zitieren
APA
Bećirović, E., Bećirović, M., Bećirović, A., Rakovac, L. T., Jagodić Ejubović, A., Čaušević, B., Ejubović, M., Ribić, A., Ferhatbegović, L., Brkić, A., Hadžić, S., Skokić, M., & Begagić, E. (2025). Approaches to rhythm control: Impact of electrical cardioversion versus pharmacological management on left atrial size and systolic performance in atrial fibrillation and flutter. Medicinski Glasnik. https://doi.org/10.17392/1830-22-01
Vancouver
Bećirović E, Bećirović M, Bećirović A, Rakovac LT, Jagodić Ejubović A, Čaušević B, et al. Approaches to rhythm control: Impact of electrical cardioversion versus pharmacological management on left atrial size and systolic performance in atrial fibrillation and flutter. Medicinski Glasnik. 2025. doi:10.17392/1830-22-01
BibTeX
@article{Beirovi2025,
author = {Bećirović, Emir and Bećirović, Minela and Bećirović, Amir and Rakovac, Lejla Tupković and Jagodić Ejubović, Amira and Čaušević, Begajeta and Ejubović, Malik and Ribić, Aida and Ferhatbegović, Lamija and Brkić, Ammar and Hadžić, Semir and Skokić, Maida and Begagić, Emir},
title = {Approaches to rhythm control: Impact of electrical cardioversion versus pharmacological management on left atrial size and systolic performance in atrial fibrillation and flutter},
journal = {Medicinski Glasnik},
year = {2025},
doi = {10.17392/1830-22-01}
}
EUVIMED